Guosen Securities pointed out that due to the increasing inc...

Guosen Securities pointed out that due to the increasing incidence of herpes zoster and the significant disease burden, the outlook for the herpes zoster vaccine market is optimistic. With the rapid growth of GlaxoSmithKline's Shingrix vaccine after its launch, it may drive further development of the entire market. It is forecasted that by 2032, the vaccination rate for the domestic population aged 50 and above could reach 15%, with the market size expected to exceed 30 billion yuan.